Canalblog
Editer l'article Suivre ce blog Administration + Créer mon blog
Publicité
Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)
26 mai 2015

BENEFIT FROM THE COMPREHENSIVE OFFERING OF DRUG DISCOVERY PRODUCTS AND SERVICES

 

rhfg22884-lr_345x235

eurofins_french_worldmap_2013

 

 

Eurofins France

Le groupe français de biotechnologies Eurofins Scientific, fondé à Nantes en 1987, figure parmi les premiers prestataires mondiaux sur le marché de la bioanalyse.

http://www.eurofins.fr



 

 

 

 

 

 

Eurofins Pharma Discovery Services  
BENEFIT FROM THE COMPREHENSIVE OFFERING OF DRUG DISCOVERY PRODUCTS AND SERVICES

After merging Eurofins Panlabs Cerep with the Discovery & Development Solutions business acquired from EMD/Merck Millipore, Eurofins Pharma Discovery Services now has a comprehensive offering of solutions for drug discovery research. With our broad portfolio Eurofins Pharma Discovery Services can be a trusted partner throughout your drug discovery program.

Download our new brochure to learn about all of our capabilities for Target ID, Screening, Hit to Lead, Lead Optimization and Candidate Selection. 

 

DID YOU KNOW?

Eurofins Pharma Discovery Services now has a new website!  Click here to explore all of our entire offerings.

IN THIS ISSUE

 

REMINDER OF UPCOMING COMPOUND SUBMISSION DATES

 

OncoPanel™
 
JULY 16
  
CardiacProfiler™ 
 
MAY 29
     
 
JULY 6
     
 
JULY 31

 

IN VITRO PHARMACOLOGY

New additions to our Kinase Products and Services

Eurofins Pharma Discovery Services continues to expand upon our broad portfolio of kinase products and services. New targets in our kinase offering include products for A-Raf, DDR1 and PKR we also now offer services for the DNAPK, A-Raf and PKR targets as well. Click here to explore our entire range of kinase products and services. 

Download PIKK Enzyme Panel Poster

CELL BASED PHENOTYPIC SCREENING 

Epigenetic Screening with OncoPanel™ - visit Eurofins at WPC 2015

Epigenetic target inhibition may exhibit delayed drug responses undetected by short-term cell growth assays. The OncoPanel™ profiling assay of 240 genomically characterized cell lines is optimized for subconfluent exponential growth over 10 day cultures. 

Visit Eurofins in Booth #9 at the World Preclinical Congress 2015or attend the WPC talk by Don Axworthy at 9:35am on Friday, June 12th to specifically learn about Epigenetic Screening with OncoPanel™.

Visit our booth #2064 at WPC2015

ADME-TOX

Complete range of in vitro ADME services

Eurofins Pharma Discovery Services has a diverse set of in vitro ADME assays to determine the bioavailability of your compounds. Our services include but aren’t limited to aqueous solubility, protein binding, in vitro absorption, in vitro metabolism and permeability studies. To learn more about our bioavailability services or all of our other ADME solutions click here 

Learn more about our Bioavailability Services

IN VIVO / PRECLINICAL

Discuss In Vivo Oncology Models at ASCO 2015

Eurofins Pharma Discovery Services has 220 in vivo disease models to support discovery research of which over 20 models are for oncology. At ASCO 2015 visit Eurofins in  Booth #2064 to learn more about our line of in vivo models for oncology studies. 

 

UPCOMING EVENTS...

Interested in meeting us? We’ll be at the tradeshows below, contact us to schedule a meeting.

» APT – Applied Pharmaceutical Toxicology 2015
La Jolla, CA – USA | May 27 – 29 

» ASCO – American Society of Clinical Oncology 2015
Booth #2064 
Chicago, IL – USA | May 29 – Jun 2

» WPC - World Preclinical Congress 2015
Booth #9 
Boston, MA – USA | June 10 – 12 

» BIO USA International Convention 2015
Booth #4351
Philadelphia, PA – USA | June 15 – 18

» ISSX European Meeting
Booth #304 
Glasgow, Scotland | June 22 – 25

» Japan SOT Annual Meeting 
Ishikawa, Japan | Jun 29 – July 1 

 

HELPFUL TIPS

Eurofins offers over 500 biochemical, cellular, and binding assays with in-house produced kinases which are also available for purchase. Run your own studies or partner with us to outsource your kinase profiling project. 

Browse our catalog of available products here »

 

 
Eurofins Cerep Panlabs and Eurofins DDS
You are receiving this e-mail because you are a friend of Eurofins Pharma Discovery Services. If you wish not to receive these emails, please unsubscribe by clicking here.
Tell your friends about us by clicking here. 

Copyright © 2015 Eurofins Panlabs, Inc. All rights reserved.
Eurofins Cerep Panlabs and Eurofins Discovery Services are brands of Eurofins Pharma Discovery Services division. Eurofins Panlabs, Inc., Eurofins Panlabs Taiwan, Ltd. and Eurofins Cerep S.A. are independent members of Eurofins Cerep Panlabs. Eurofins Pharma Bioanalytics Services US Inc. and Eurofins Pharma Discovery Services UK Ltd are independent members of Eurofins Discovery Services. 

This email was sent by: Eurofins Panlabs, Inc. 15318 NE 95th Street Redmond, WA. USA.

Publicité
Publicité
Commentaires
Publicité
Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)
Newsletter
Visiteurs
Depuis la création 33 340
Publicité